| Literature DB >> 29720035 |
S Qi1, Q Chen1, D Xu1, N Xie1, Y Dai2.
Abstract
Systemic lupus erythematosus (SLE) is a type of autoimmune disease that damages multiple organs, including the heart, joints, liver and kidneys. The main characteristics of SLE are the deposition of circulating autoantibodies; autoantigen complexes in the renal system; and abnormal expression of complements, cytokines and chemokines. Lupus nephritis (LN) is the most serious manifestation of SLE and is characterized by inflammation of the kidney. This review summarizes recent clinical applications of protein biomarkers including autoantibodies, complements, cytokines and chemokines and some new protein biomarkers in SLE and LN. The clinical differential diagnosis of protein biomarkers related to prognosis and diagnosis is discussed and highlighted. Protein biomarkers play crucial roles in the study of SLE and LN. Useful biomarkers will provide insights into effective treatments for these diseases.Entities:
Keywords: Systemic lupus erythematosus; autoantibody; complements; lupus nephritis; protein biomarkers
Mesh：
Substances：
Year: 2018 PMID： 29720035 DOI： 10.1177/0961203318773643
Source DB: PubMed Journal: Lupus ISSN： 0961-2033 Impact factor: 2.911